Ling Lin

789 total citations · 1 hit paper
19 papers, 577 citations indexed

About

Ling Lin is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Ling Lin has authored 19 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 7 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Ling Lin's work include Immune Cell Function and Interaction (4 papers), Immune Response and Inflammation (4 papers) and interferon and immune responses (3 papers). Ling Lin is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Immune Response and Inflammation (4 papers) and interferon and immune responses (3 papers). Ling Lin collaborates with scholars based in China, United States and France. Ling Lin's co-authors include Andrea Gerth, Stanford L. Peng, Ching-Man Virbasius, Lihua Julie Zhu, Jianhong Ou, Lynn Chamberlain, Narendra Wajapeyee, Jogender S. Tushir, Sanchita Bhatnagar and Xiaochun Zhu and has published in prestigious journals such as Nature, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Ling Lin

19 papers receiving 570 citations

Hit Papers

Nano drug delivery systems for advanced immune checkpoint... 2025 2026 2025 10 20 30 40 50

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Lin China 10 253 228 112 61 51 19 577
Annika Frede Germany 13 186 0.7× 282 1.2× 110 1.0× 38 0.6× 28 0.5× 17 611
Abdellatif Bouazzaoui Saudi Arabia 16 158 0.6× 196 0.9× 62 0.6× 40 0.7× 21 0.4× 45 637
Fu‐Fei Hsu Taiwan 11 161 0.6× 316 1.4× 117 1.0× 47 0.8× 45 0.9× 15 636
Shibichakravarthy Kannan United States 9 157 0.6× 206 0.9× 91 0.8× 56 0.9× 68 1.3× 12 625
Dickson Adah China 15 220 0.9× 288 1.3× 76 0.7× 73 1.2× 48 0.9× 22 714
Mateusz Kwitniewski Poland 13 206 0.8× 105 0.5× 92 0.8× 115 1.9× 97 1.9× 27 583
Jian Hu China 12 140 0.6× 224 1.0× 52 0.5× 32 0.5× 41 0.8× 39 477
Brian Schanen United States 11 171 0.7× 333 1.5× 86 0.8× 78 1.3× 34 0.7× 17 715
K. Callaghan Australia 6 161 0.6× 157 0.7× 104 0.9× 40 0.7× 23 0.5× 11 572

Countries citing papers authored by Ling Lin

Since Specialization
Citations

This map shows the geographic impact of Ling Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Lin more than expected).

Fields of papers citing papers by Ling Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Lin. The network helps show where Ling Lin may publish in the future.

Co-authorship network of co-authors of Ling Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Lin. A scholar is included among the top collaborators of Ling Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Lin. Ling Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Guo, Chenqi, Ling Lin, Yihan Wang, et al.. (2025). Nano drug delivery systems for advanced immune checkpoint blockade therapy. Theranostics. 15(11). 5440–5480. 52 indexed citations breakdown →
2.
Zheng, Quan, et al.. (2025). Identification and validation of CKAP2 as a novel biomarker in the development and progression of rheumatoid arthritis. Frontiers in Immunology. 16. 1606201–1606201. 1 indexed citations
3.
Deng, Mengqing, et al.. (2025). Structural and Transcriptional Plasticity of OBP3 Confers Insecticide Adaptation in Spodoptera litura. Journal of Agricultural and Food Chemistry. 73(31). 19340–19352. 1 indexed citations
4.
Cao, Yuhua, Shuaishuai Ding, Yunping Hu, et al.. (2024). An Immunocompetent Hafnium Oxide-Based STING Nanoagonist for Cancer Radio-immunotherapy. ACS Nano. 18(5). 4189–4204. 42 indexed citations
5.
Liu, Xiaosheng, Xiuxia Li, Jing Xue, et al.. (2023). Comprehensive transcriptomic analyses identify the immunosuppressive effects of LLDT-8 in ART-treated SIV-infected rhesus macaques. International Immunopharmacology. 126. 111173–111173. 1 indexed citations
6.
Ma, Wen, Rui Sun, Longguang Tang, et al.. (2023). Bioactivable STING Nanoagonists to Synergize NIR‐II Mild Photothermal Therapy Primed Robust and Long‐Term Anticancer Immunity. Advanced Materials. 35(48). e2303149–e2303149. 69 indexed citations
7.
Lin, Ling, et al.. (2022). Atomic‐Scale View of Protein‐PEG Interactions that Redirect the Thermal Unfolding Pathway of PEGylated Human Galectin‐3. Angewandte Chemie International Edition. 61(40). e202203784–e202203784. 5 indexed citations
8.
Li, Zhen, Lishan Zhang, Lina Sun, et al.. (2021). Proteomics analysis reveals the importance of transcriptional regulator slyA in regulation of several physiological functions in Aeromonas hydrophila. Journal of Proteomics. 244. 104275–104275. 7 indexed citations
9.
Yang, Yongqiang, Tang Li, Jingyuan Wan, et al.. (2020). Therapeutic benefits of apocynin in mice with lipopolysaccharide/D-galactosamine-induced acute liver injury via suppression of the late stage pro-apoptotic AMPK/JNK pathway. Biomedicine & Pharmacotherapy. 125. 110020–110020. 34 indexed citations
10.
Lin, Ling, Yang Han, Xiaojing Song, et al.. (2020). Whole blood as an alternative to peripheral blood mononuclear cell for detection of total HIV-1 DNA. BMC Infectious Diseases. 20(1). 941–941. 3 indexed citations
11.
Lin, Ling, et al.. (2019). Application of UPLC-MS/MS for Simultaneous Determination of Malachite Green and Metabolites Residues in Tilapia. IOP Conference Series Materials Science and Engineering. 563(5). 52062–52062. 1 indexed citations
12.
Lin, Xiangmin, Ling Lin, Zujie Yao, et al.. (2015). An Integrated Quantitative and Targeted Proteomics Reveals Fitness Mechanisms of Aeromonas hydrophila under Oxytetracycline Stress. Journal of Proteome Research. 14(3). 1515–1525. 43 indexed citations
13.
Bhatnagar, Sanchita, Claude Gazin, Lynn Chamberlain, et al.. (2014). TRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoprotein. Nature. 516(7529). 116–120. 137 indexed citations
14.
Lin, Ling, Ziyang Huang, Xiaohong Chen, et al.. (2013). Role of Toll-Like Receptor 4 on Lupus Lung Injury and Atherosclerosis in LPS-Challenge ApoE−/−Mice. SHILAP Revista de lepidopterología. 2013. 1–12. 23 indexed citations
15.
Huang, Mingqing, Youliang Xie, Xiao‐Ping Lai, et al.. (2012). Protection of Total Flavonoid Fraction from Nervilia fordii on Lipopolysaccharide-induced Acute Lung Injury in Rats. Chinese Herbal Medicines. 4(4). 287–293. 1 indexed citations
17.
Pan, Jingxin, et al.. (2006). [Effect of reduced glutathione as anti-leukemic immune adjuvant].. PubMed. 14(2). 359–62. 2 indexed citations
18.
Lin, Ling, Andrea Gerth, & Stanford L. Peng. (2004). CpG DNA redirects class‐switching towards "Th1‐like" Ig isotype production via TLR9 and MyD88. European Journal of Immunology. 34(5). 1483–1487. 121 indexed citations
19.
Gerth, Andrea, Ling Lin, Markus F. Neurath, Laurie H. Glimcher, & Stanford L. Peng. (2004). An innate cell-mediated, murine ulcerative colitis-like syndrome in the absence of nuclear factor of activated T cells☆. Gastroenterology. 126(4). 1115–1121. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026